Oi SA QIBRD
—
4.01
0.00
0.00%
as of 20 Nov
- Market cap
- —
- P/E
- 0.0×
Follow QIBRD
| Sep '21 | Jun '21 | Mar '21 | Dec '20 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
6.48 | 3.45 | 2.12 | 1.64 | |
P/FCF ratio |
55.91 | 23.67 | 6.39 | 13.90 | |
P/Operating CF |
11.81 | (6.53) | (29.41) | 19.05 | |
P/B ratio |
8.36 | 2.22 | 3.09 | 1.96 | |
Price to Tangible BV |
0.00 | 5.19 | 17.72 | 3.74 | |
EV/Sales |
3.70 | 1.80 | 2.73 | 2.03 | |
EV/EBITDA |
21.87 | 5.67 | 10.25 | 7.44 | |
EV/Operating CF |
(6.27) | 24.05 | 4.74 | 4.27 | |
EV/FCF |
31.89 | 12.32 | 8.21 | 17.19 | |
Quick Ratio |
1.80 | 1.50 | 1.26 | 1.63 | |
Current Ratio |
1.97 | 1.67 | 1.50 | 1.88 | |
Net Debt/EBITDA |
(7.87) | (10.79) | 2.85 | (1.75) | |
Debt/Assets |
44.72% | 38.74% | 39.04% | 38.83% | |
Debt/Equity |
31.30 | 4.94 | 6.60 | 3.69 | |
Asset Turnover |
0.02 | 0.05 | 0.08 | 0.11 | |
Operating CF/Net income |
(0.16) | (1.75) | 0.13 | 0.31 | |
Capex/Depreciation |
(1.04) | 0.71 | (0.57) | (3.55) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
46.12% | 49.82% | 50.82% | (11.69%) | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.05 | 0.05 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(3.12) | (1.93) | (2.56) | (2.12) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(53.46%) | (18.30%) | (55.43%) | (69.62%) | |
Free Cash Flow Yield |
1.79% | 4.23% | 15.64% | 7.19% | |
Revenue per Share |
14.43 | 14.08 | 13.76 | (34.32) | |
Operating CF per Share |
4.91 | (12.55) | (2.76) | 5.35 | |
Capex per Share |
(7.46) | 3.40 | (4.08) | 14.82 | |
Free Cash Flow per Share |
(2.55) | (9.15) | (6.84) | 20.18 | |
Cash per Share |
242.13 | 222.07 | 150.42 | 167.84 | |
Shareholders Equity per Share |
6.94 | 37.01 | 26.30 | 52.01 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.94 | 37.01 | 26.30 | 52.01 | |
Free Cash Flow |
(75.99) | (274.28) | (203.57) | 584.71 | |
Working Capital |
4,367.96 | 3,309.19 | 2,076.20 | 3,061.83 | |
Capital Expenditures |
(222.10) | 101.97 | (121.39) | 429.56 | |
Net Current Asset Value |
(5,389.66) | (4,751.89) | (6,185.48) | (6,261.19) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.52 | (0.24) | 0.30 | 0.43 | |
Net Profit Margin |
(214.49%) | 50.97% | (156.55%) | (50.54%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1,071.96 | 1,047.17 | 1,150.91 | 1,317.47 | |
Average Payables |
775.24 | 773.52 | 916.89 | 1,062.40 | |
Average Inventory |
68.86 | 69.46 | 76.64 | 76.83 | |
Average Assets |
13,989.58 | 13,891.44 | 14,962.66 | 16,358.22 | |
Average Common Equity |
661.83 | 1,315.96 | 1,701.24 | 3,287.90 |
Columns are period end dates